A serpin shapes the extracellular environment to prevent influenza a virus maturation

Cell

Volumn 160, Issue 4, 2015, Pages 631-643

  Dittmann, Meike ^a   Hoffmann, Hans Heinrich ^a   Scull, Margaret A ^a   Gilmore, Rachel H ^a   Bell, Kierstin L ^a   Ciancanelli, Michael ^a   Wilson, Sam J ^a,b   Crotta, Stefania ^c   Yu, Yingpu ^a   Flatley, Brenna ^a   Xiao, Jing W ^a   Casanova, Jean Laurent ^a,d,e,f,g   Wack, Andreas ^c   Bieniasz, Paul D ^a   Rice, Charles M ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^e IMAGINE INSTITUTE   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GLYCOPROTEIN; INFLUENZA VIRUS HEMAGGLUTININ; INTERFERON REGULATORY FACTOR 2; INTERFERON REGULATORY FACTOR 7; LENTIVIRUS VECTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERINE PROTEINASE INHIBITOR; TRYPSIN; PROTEASE NEXIN I; SERINE PROTEINASE; SERPINE1 PROTEIN, HUMAN; SERPINE2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYSIS; CELL LYSATE; CONTROLLED STUDY; FEMALE; FIBROBLAST; FIBROBLAST CULTURE; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLUENZA A; INFLUENZA VIRUS A; INNATE IMMUNITY; LIFE CYCLE; LUNG CANCER CELL LINE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN SECRETION; RESPIRATORY EPITHELIUM; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; VECTOR CONTROL; VESICULOVIRUS; VIROGENESIS; VIRUS REPLICATION; WILD TYPE; ANIMAL; C57BL MOUSE; CELL LINE; ENZYMOLOGY; GENETICS; INFLUENZA A VIRUS; METABOLISM; PHYSIOLOGY; RESPIRATORY SYSTEM; VIROLOGY;

INFLUENZA A VIRUS;

ANIMALS; CELL LINE; HUMANS; IMMUNITY, INNATE; INFLUENZA A VIRUS; MICE, INBRED C57BL; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESPIRATORY SYSTEM; SERINE PROTEASES; SERPIN E2;

EID: 84922723424     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2015.01.040     Document Type: Article

References (53)

1. Y. Beppu, Y. Imamura, M. Tashiro, T. Towatari, H. Ariga, and H. Kido Human mucus protease inhibitor in airway fluids is a potential defensive compound against infection with influenza A and Sendai viruses J. Biochem. 121 1997 309 316
2. M.B. Berkenpas, D.A. Lawrence, and D. Ginsburg Molecular evolution of plasminogen activator inhibitor-1 functional stability EMBO J. 14 1995 2969 2977
3. D. Bernot, J. Stalin, P. Stocker, B. Bonardo, I. Scroyen, M.C. Alessi, and F. Peiretti Plasminogen activator inhibitor 1 is an intracellular inhibitor of furin proprotein convertase J. Cell Sci. 124 2011 1224 1230
4. S. Bertram, I. Glowacka, P. Blazejewska, E. Soilleux, P. Allen, S. Danisch, I. Steffen, S.Y. Choi, Y. Park, and H. Schneider TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells J. Virol. 84 2010 10016 10025
5. S. Bertram, I. Glowacka, I. Steffen, A. Kühl, and S. Pöhlmann Novel insights into proteolytic cleavage of influenza virus hemagglutinin Rev. Med. Virol. 20 2010 298 310
6. F.X. Bosch, W. Garten, H.D. Klenk, and R. Rott Proteolytic cleavage of influenza virus hemagglutinins: primary structure of the connecting peptide between HA1 and HA2 determines proteolytic cleavability and pathogenicity of Avian influenza viruses Virology 113 1981 725 735
7. E. Böttcher, T. Matrosovich, M. Beyerle, H.D. Klenk, W. Garten, and M. Matrosovich Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium J. Virol. 80 2006 9896 9898
8. E. Böttcher-Friebertshäuser, D.A. Stein, H.D. Klenk, and W. Garten Inhibition of influenza virus infection in human airway cell cultures by an antisense peptide-conjugated morpholino oligomer targeting the hemagglutinin-activating protease TMPRSS2 J. Virol. 85 2011 1554 1562
9. B.A. Brody, S.S. Rhee, M.A. Sommerfelt, and E. Hunter A viral protease-mediated cleavage of the transmembrane glycoprotein of Mason-Pfizer monkey virus can be suppressed by mutations within the matrix protein Proc. Natl. Acad. Sci. USA 89 1992 3443 3447
10. C.M. Carlson, E.A. Turpin, L.A. Moser, K.B. O'Brien, T.D. Cline, J.C. Jones, T.M. Tumpey, J.M. Katz, L.A. Kelley, J. Gauldie, and S. Schultz-Cherry Transforming growth factor-β: activation by neuraminidase and role in highly pathogenic H5N1 influenza pathogenesis PLoS Pathog. 6 2010 e1001136
11. P.J. Declerck, and A. Gils Three decades of research on plasminogen activator inhibitor-1: a multifaceted serpin Semin. Thromb. Hemost. 39 2013 356 364
12. W.P. Fay, A.C. Parker, L.R. Condrey, and A.D. Shapiro Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene Blood 90 1997 204 208
13. S.E. Galloway, M.L. Reed, C.J. Russell, and D.A. Steinhauer Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation PLoS Pathog. 9 2013 e1003151
14. I. Glowacka, S. Bertram, M.A. Müller, P. Allen, E. Soilleux, S. Pfefferle, I. Steffen, T.S. Tsegaye, Y. He, and K. Gnirss Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response J. Virol. 85 2011 4122 4134
15. K.L. Hartshorn, M.R. White, T. Tecle, U. Holmskov, and E.C. Crouch Innate defense against influenza A virus: activity of human neutrophil defensins and interactions of defensins with surfactant protein D J. Immunol. 176 2006 6962 6972
16. B. Hatesuer, S. Bertram, N. Mehnert, M.M. Bahgat, P.S. Nelson, S. Pöhlman, and K. Schughart Tmprss2 is essential for influenza H1N1 virus pathogenesis in mice PLoS Pathog. 9 2013 e1003774
17. W. He, R. Tan, C. Dai, Y. Li, D. Wang, S. Hao, M. Kahn, and Y. Liu Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/beta-catenin signaling J. Biol. Chem. 285 2010 24665 24675
18. T. Horimoto, K. Nakayama, S.P. Smeekens, and Y. Kawaoka Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses J. Virol. 68 1994 6074 6078
19. J.A. Irving, R.N. Pike, A.M. Lesk, and J.C. Whisstock Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function Genome Res. 10 2000 1845 1864
20. T.T. Keller, K.F. van der Sluijs, M.D. de Kruif, V.E. Gerdes, J.C. Meijers, S. Florquin, T. van der Poll, E.C. van Gorp, D.P. Brandjes, H.R. Büller, and M. Levi Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1 Circ. Res. 99 2006 1261 1269
21. H. Kido, Y. Okumura, E. Takahashi, H.Y. Pan, S. Wang, D. Yao, M. Yao, J. Chida, and M. Yano Role of host cellular proteases in the pathogenesis of influenza and influenza-induced multiple organ failure Biochim. Biophys. Acta 1824 2012 186 194
22. H.D. Klenk, R. Rott, M. Orlich, and J. Blödorn Activation of influenza A viruses by trypsin treatment Virology 68 1975 426 439
23. A.A. Komissarov, P.A. Andreasen, J.S. Bødker, P.J. Declerck, J.Y. Anagli, and J.D. Shore Additivity in effects of vitronectin and monoclonal antibodies against alpha-helix F of plasminogen activator inhibitor-1 on its reactions with target proteinases J. Biol. Chem. 280 2005 1482 1489
24. D.A. Lawrence, S.T. Olson, S. Palaniappan, and D. Ginsburg Serpin reactive center loop mobility is required for inhibitor function but not for enzyme recognition J. Biol. Chem. 269 1994 27657 27662
25. S.G. Lazarowitz, and P.W. Choppin Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide Virology 68 1975 440 454
26. S.G. Lazarowitz, A.R. Goldberg, and P.W. Choppin Proteolytic cleavage by plasmin of the HA polypeptide of influenza virus: host cell activation of serum plasminogen Virology 56 1973 172 180
27. W.M. Lee, S.S. Monroe, and R.R. Rueckert Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome J. Virol. 67 1993 2110 2122
28. M.G. Lee, K.H. Kim, K.Y. Park, and J.S. Kim Evaluation of anti-influenza effects of camostat in mice infected with non-adapted human influenza viruses Arch. Virol. 141 1996 1979 1989
29. O. Lenz, J. ter Meulen, H.D. Klenk, N.G. Seidah, and W. Garten The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P Proc. Natl. Acad. Sci. USA 98 2001 12701 12705
30. B. Mangeat, L. Cavagliotti, M. Lehmann, G. Gers-Huber, I. Kaur, Y. Thomas, L. Kaiser, and V. Piguet Influenza virus partially counteracts restriction imposed by tetherin/BST-2 J. Biol. Chem. 287 2012 22015 22029
31. R.L. Medcalf Fibrinolysis, inflammation, and regulation of the plasminogen activating system J. Thromb. Haemost. 5 1 2007 132 142
32. S.J.D. Neil, T. Zang, and P.D. Bieniasz Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu Nature 451 2008 425 430
33. T. Ny, M. Sawdey, D. Lawrence, J.L. Millan, and D.J. Loskutoff Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor Proc. Natl. Acad. Sci. USA 83 1986 6776 6780
34. S.T. Olson, R. Swanson, D. Day, I. Verhamme, J. Kvassman, and J.D. Shore Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1, with tissue plasminogen activator and trypsin Biochemistry 40 2001 11742 11756
35. P.C. Reading, S. Bozza, B. Gilbertson, M. Tate, S. Moretti, E.R. Job, E.C. Crouch, A.G. Brooks, L.E. Brown, and B. Bottazzi Antiviral activity of the long chain pentraxin PTX3 against influenza viruses J. Immunol. 180 2008 3391 3398
36. K. Sakai, Y. Ami, M. Tahara, T. Kubota, M. Anraku, M. Abe, N. Nakajima, T. Sekizuka, K. Shirato, and Y. Suzaki The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses J. Virol. 88 2014 5608 5616
37. W.M. Schneider, M.D. Chevillotte, and C.M. Rice Interferon-stimulated genes: a complex web of host defenses Annu. Rev. Immunol. 32 2014 513 545
38. J.W. Schoggins, S.J. Wilson, M. Panis, M.Y. Murphy, C.T. Jones, P. Bieniasz, and C.M. Rice A diverse range of gene products are effectors of the type I interferon antiviral response Nature 472 2011 481 485
39. J.W. Schoggins, D.A. MacDuff, N. Imanaka, M.D. Gainey, B. Shrestha, J.L. Eitson, K.B. Mar, R.B. Richardson, A.V. Ratushny, and V. Litvak Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity Nature 505 2014 691 695
40. J.J. Skehel, and M.D. Waterfield Studies on the primary structure of the influenza virus hemagglutinin Proc. Natl. Acad. Sci. USA 72 1975 93 97
41. J. Steel, A.C. Lowen, L. Pena, M. Angel, A. Solórzano, R. Albrecht, D.R. Perez, A. García-Sastre, and P. Palese Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza J. Virol. 83 2009 1742 1753
42. D.A. Steinhauer, and R.K. Plemper Structure of the primed paramyxovirus fusion protein Proc. Natl. Acad. Sci. USA 109 2012 16404 16405
43. A. Stieneke-Gröber, M. Vey, H. Angliker, E. Shaw, G. Thomas, C. Roberts, H.D. Klenk, and W. Garten Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease EMBO J. 11 1992 2407 2414
44. C. Tarnow, G. Engels, A. Arendt, F. Schwalm, H. Sediri, A. Preuss, P.S. Nelson, W. Garten, H.D. Klenk, G. Gabriel, and E. Böttcher-Friebertshäuser TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice J. Virol. 88 2014 4744 4751
45. M. Tashiro, H.D. Klenk, and R. Rott Inhibitory effect of a protease inhibitor, leupeptin, on the development of influenza pneumonia, mediated by concomitant bacteria J. Gen. Virol. 68 1987 2039 2041
46. M. Tashiro, Y. Yokogoshi, K. Tobita, J.T. Seto, R. Rott, and H. Kido Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity J. Virol. 66 1992 7211 7216
47. J. Turner, and C.E. Jones Regulation of mucin expression in respiratory diseases Biochem. Soc. Trans. 37 2009 877 881
48. V.E. Volchkov, H. Feldmann, V.A. Volchkova, and H.D. Klenk Processing of the Ebola virus glycoprotein by the proprotein convertase furin Proc. Natl. Acad. Sci. USA 95 1998 5762 5767
49. X. Wang, E.R. Hinson, and P. Cresswell The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts Cell Host Microbe 2 2007 96 105
50. R. Watanabe, G.P. Leser, and R.A. Lamb Influenza virus is not restricted by tetherin whereas influenza VLP production is restricted by tetherin Virology 417 2011 50 56
51. M.A. Yondola, F. Fernandes, A. Belicha-Villanueva, M. Uccelini, Q. Gao, C. Carter, and P. Palese Budding capability of the influenza virus neuraminidase can be modulated by tetherin J. Virol. 85 2011 2480 2491
52. Z.Y. Zhang, Z.Y. Wang, N.Z. Dong, X. Bai, W. Zhang, and C.G. Ruan A case of deficiency of plasma plasminogen activator inhibitor-1 related to Ala15Thr mutation in its signal peptide Blood Coagul. Fibrinolysis 16 2005 79 84
53. O.P. Zhirnov, T.Y. Matrosovich, M.N. Matrosovich, and H.D. Klenk Aprotinin, a protease inhibitor, suppresses proteolytic activation of pandemic H1N1v influenza virus Antivir. Chem. Chemother. 21 2011 169 174